Showing results (61-70 of 493) with videos related to
Sort By:
Pageof 50
Psychiatry and Clinical Neurosciences|October 24, 2017
Genome-wide association studies of bipolar disorder: A systematic review of recent findings and their clinical implicationsMasashi Ikeda, Takeo Saito, Kenji Kondo, et al.Journal of Alzheimer'S Disease : JAD|September 25, 2015
Histamine H3 Receptor Antagonists for Alzheimer's Disease: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled TrialsMomoko Kubo, Taro Kishi, Shinji Matsunaga, et al.Fujita Medical Journal|February 3, 2022
Retrospective analysis of the incidence of neurodegenerative disorders in idiopathic rapid eye movement sleep behavior disorder: a preliminary study in Japanese patientsReiko Kumagai, Tsuyoshi Kitajima, Marina Hirose, et al.Neuropsychopharmacology Reports|July 9, 2019
Quetiapine extended-release vs olanzapine for Japanese patients with bipolar depression: A Bayesian analysisTaro Kishi, Toshikazu Ikuta, Yuki Matsuda, et al.Frontiers in Psychiatry|February 2, 2018
Brain-Derived Neurotrophic Factor and Major Depressive Disorder: Evidence from Meta-AnalysesTaro Kishi, Reiji Yoshimura, Toshikazu Ikuta, et al.The Journal of Clinical Psychiatry|January 18, 2014
Antipsychotics for cocaine or psychostimulant dependence: systematic review and meta-analysis of randomized, placebo-controlled trialsTaro Kishi, Yuki Matsuda, Nakao Iwata, et al.Journal of Psychiatric Research|August 1, 2013
Efficacy and safety of noradrenalin reuptake inhibitor augmentation therapy for schizophrenia: a meta-analysis of double-blind randomized placebo-controlled trialsTaro Kishi, Tomohiko Mukai, Yuki Matsuda, et al.The International Journal of Neuropsychopharmacology|June 21, 2015
Protection against Brain Atrophy by Anti-dementia Medication in Mild Cognitive Impairment and Alzheimer's Disease: Meta-Analysis of Longitudinal Randomized Placebo-Controlled TrialsTaro Kishi, Shinji Matsunaga, Kazuto Oya, et al.Journal of Alzheimer'S Disease : JAD|November 20, 2018
Efficacy, Acceptability, and Safety of Intravenous Immunoglobulin Administration for Mild-To-Moderate Alzheimer's Disease: A Systematic Review and Meta-AnalysisMakoto Okuya, Shinji Matsunaga, Toshikazu Ikuta, et al.Psychiatry Research|July 1, 2020
Trend survey on adverse event profiles of antipsychotic long-acting injections and oral agents using the Japanese adverse drug event report databaseMasakazu Hatano, Hiroyuki Kamei, Akane Shimato, et al.Pageof 50